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Dietary polyphenols present in a broad range of plant foods have been related to beneficial health effects. This review aims to
update the current information about the modulation of the gut microbiota by dietary phenolic compounds, from a perspective
based on the experimental approaches used. After referring to general aspects of gut microbiota and dietary polyphenols, studies
related to this topic are presented according to their experimental design: batch culture fermentations, gastrointestinal simulators,
animal model studies, and human intervention studies. In general, studies evidence that dietary polyphenols may contribute to
the maintenance of intestinal health by preserving the gut microbial balance through the stimulation of the growth of beneficial
bacteria (i.e., lactobacilli and bifidobacteria) and the inhibition of pathogenic bacteria, exerting prebiotic-like effects. Combination
of in vitro and in vivo models could help to understand the underlying mechanisms in the polyphenols-microbiota-host triangle
and elucidate the implications of polyphenols on human health. From a technological point of view, supplementation with rich-
polyphenolic stuffs (phenolic extracts, phenolic-enriched fractions, etc.) could be an effective option to improve health benefits of
functional foods such as the case of dairy fermented foods.
1. Introduction
More and more studies confirm the importance of the gut
microbiota in host health, including mental health. Gut
bacteria not only help us to maximize the absorption of
nutrients and energy, but also are essential in the body health
status [1]. In particular, microbial infections and imbalances
in the composition of the gut microbiota are associated
with intestinal disorders such as chronic inflammatory bowel
diseases and with other immune related disorders [2, 3].
Although genetic and environmental factors are main deter-
minants of gut microbiota composition, it is well established
that diet influences microbial fermentation and total bacteria
in the intestine. In fact, interindividual variation in gut
microbiota may, in part, reflect differences in dietary intake,
although the response of the gutmicrobiota to dietary change
can also differ among individuals [4].
Phenolic compounds or polyphenols are secondarymeta-
bolites with awidespread occurrence in the plant kingdom. In
nature, polyphenols can be classified into two major groups:
flavonoids and nonflavonoids. Among flavonoids, various
groups can be distinguished according to the C-heterocycle
structure: flavonols, flavones, flavan-3-ols, isoflavones, fla-
vanones, dihydroflavonols, anthocyanidins, and chalcones
(Figure 1). Nonflavonoid phenolics include phenolic acids,
hydrolysable tannins, and stilbenes, among others. Polyphe-
nols also form part of the human diet, being present in a
broad range of commonly consumed fruits, vegetables, and
plant-derived products such as cocoa, tea, or wine. A number
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Figure 1: Common phenolic compounds in food.
of epidemiological studies have shown that the intake of
diets rich in fruits and vegetables is inversely associated with
the risk of various chronic diseases, such as coronary heart
disease, specific cancers, and neurodegenerative disorders
[5–7]. Indeed, a range of pharmacological effects have been
demonstrated for different phenolic compounds—especially
flavonoids—through in vitro, ex vivo and animal assays [8, 9].
However, health effects of these compounds depend on their
bioavailability and, therefore, it is important to understand
how they are absorbed, metabolized, and eliminated from the
body, in order to ascertain their in vivo actions.
Modulation of gut microbiota by polyphenols has been
a topic of increasing attention by the scientific community
in the last years. Several studies have been carried out by
different authors ranging from the simplest experimental
approaches on the effect of polyphenols on the growth
of isolated intestinal bacteria to complex approximations
implying the whole fecal microbiota, either in fermentation
experiments (batch cultures and continuous simulators) or
through compositional analysis of animal and human fecal
samples.The existing knowledge about relationships between
polyphenols and gut microbiota has been object of many
reviews from different perspectives. Thus, some authors
have put their attention on the impact of food constituents
(polyphenols included) in the gut microbiome [10, 11], while
others have focused on the effects of dietary polyphenols
on microbial modulation and their potential implications
in human health [12–15]. Selma et al. [16] wrote probably
the first review trying to put together the concepts of
microbial degradation of polyphenols and modulation of
gut microbiota by polyphenols and phenolic metabolites.
This two-way interaction between phenolics and intestinal
bacteria has been also reviewed focusing on wine [17] and
tea polyphenols [18]. The development of improved biology
and microbial techniques has allowed notable advances in
the knowledge of the gut microbiota and their modulation
by dietary components and hence polyphenols.The potential
of the novel metabolomic approaches in the study of the
impact of polyphenols on gut microbiome has been recently
reviewed [19].
Being aware of all this previous reviewing work, we have
aimed to update the available information about modulation
of gut microbiota by dietary polyphenols with a perspective
based on the experimental approaches used. After two gen-
eral sections covering relevant aspects about gut microbiota
(Section 2) and dietary polyphenols (Section 3), studies are
presented according to their experimental design: batch
culture fermentations (Section 4), gastrointestinal simulators
(Section 5), animal model studies (Section 6), and human
intervention studies (Section 7). Main findings and general
conclusions generated from the different types of studies are
finally discussed (Section 8).
2. Gut Microbiota Composition and Analysis
The human gut is the natural habitat of a large, diverse pop-
ulation and dynamics of microorganisms, mainly anaerobic
bacteria, which have adapted to life on mucosal surfaces
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in the gut lumen. The acquisition of gut microbiota begins
at birth and is strongly influenced by a range of factors
that include host genetics, immunological factors, antibiotic
usage, and also dietary habits [20]. The microbial content of
the gastrointestinal tract changes along its length, ranging
from a narrow diversity and low numbers of microbes in
the stomach to a wide diversity and high numbers in the
large intestine, which can reach 1012 CFU/mL [21]. Most of
intestinal bacteria belong to phylum Firmicutes (including
Clostridium, Enterococcus, Lactobacillus, and Ruminococcus
genera) and Bacteroidetes (including Prevotella and Bac-
teroides genera) which constitute over 90% of known phy-
logenetic categories and dominate the distal gut microbiota
[22]. Recently, a novel classification of microbiota into three
predominant “enterotypes,” dominated by three different
genera, Bacteroides, Prevotella, and Ruminococcus, has been
suggested [23]. In this line, Wu et al. [24] demonstrated
that long-term diet high in animal proteins and fats versus
simple carbohydrates clustered the human subjects into the
previously described enterotypes Bacteroides and Prevotella.
However, there is a current debate if the enterotypes should
be seen discontinuous or as a gradient [25]. But in any case,
a common observation is that homeostasis and resilience are
coupled to a highly diverse gut microbiota in healthy people,
whereas inflammatory and metabolic disorders are linked to
perturbations in the composition and/or functions of the gut
microbiota [26].
Culture-based techniques employed to bacteria identifi-
cation are fairly cheap, laborious, and time-consuming and
gives a limited view of the diversity and dynamics of the
gastrointestinal microbiota, with less than 30% of gut micro-
biotamembers having been cultured to date [27]. Since 1990s,
the introduction of novel molecular biological procedures
has made it possible to overcome some of these limitations
with the use of culture-independent methods [28]. These
procedures are based on sequence divergences of the small
subunit ribosomal RNA (16S rRNA) and include techniques
such as denaturing gradient gel electrophoresis (DGGE),
terminal restriction fragment length polymorphism (T-
RFLP), fluorescence in situ hybridization (FISH), quantitative
polymerase chain reaction (qPCR), DNA microarrays, and
next-generation sequencing (NGS) of the 16S rRNA gene
or its amplicons [29]. NGS techniques have promoted the
emergence of new, high-throughput technologies, such as
genomics, metagenomics, transcriptomics, and metatran-
scriptomics. Metagenomics gives a more in-depth, unbiased
microbial analysis beyond the group level and involves
multiple species, besides showing shorter sequencing speed,
extended read length, and lower costs [30]. However, the
enormous amount of data generated becomes cumbersome to
analyze and requires lots of dedicated time as well as expertise
to manage [29].
In the context of polyphenol-microbiota interactions, the
emerging high-throughput meta-genomic, transcriptomic,
and proteomic approaches can be adopted to identify genes
and micro-organisms involved in polyphenol (in)activation
and conversion, to reconstruct metabolic pathways, and to
monitor how microbial communities adjust their metabolic
activities upon polyphenol exposure [30]. Application of
these technologies to human fecal samples requires fur-
ther investigation to determine how these samples reflect
metabolism inside the gut and, ultimately, to improve the
understanding of the impact of polyphenols on host health
[12, 31].
3. Dietary Polyphenols
It has been estimated that 90–95% of dietary polyphenols are
not absorbed in the small intestine and therefore reach the
colon [32], although absorption and metabolism are largely
influenced by their chemical structure. Most flavonoids are
poorly absorbed from the small intestine and are highly
metabolized in the large intestine. Isoflavones seem to be
the best absorbed dietary flavonoids; catechins, flavanones,
and flavonol glycosides are intermediate, whereas proantho-
cyanidins, flavan-3-ol gallates, and anthocyanins would be
the worst absorbed [33].
The first step in the metabolism of flavonoids, with the
exception of flavan-3-ols (i.e., catechins and proanthocyani-
dins), is likely to be deglycosylation before absorption in
the small intestine. Hydrolysis of some flavonoid glycoside
might already occur in the oral cavity, as both saliva and
oral microbiota show 𝛽-glucosidase activity. But the mech-
anism most usually assumed for flavonoid deglycosylation is
hydrolysis by lactase phlorizin hydrolase (LPH) in the brush-
border of the small intestine epithelial cells [34, 35], so that
the resulting aglycones would enter the enterocyte by passive
diffusion. The resulting aglycone is rapidly biotransformed
by phase II enzymes within the enterocyte and further in
the liver, so that conjugated metabolites (i.e., glucuronides,
O-mehtylethers, and/or sulphates) through the respective
action of UDP-glucuronosyltransferase (UGT), catechol-O-
methyltransferase (COMT), and sulphotransferases would be
the circulating forms in the human body [36, 37].
Generally, a relevant fraction of dietary flavonoids is
not absorbed in the small intestine and, together with
the conjugated metabolites that returned to the intestinal
lumen via enterohepatic circulation, reaches the large intes-
tine where compounds are subjected to the action of the
colonic microbiota. Intestinal bacteria show diverse degly-
cosylating activities, thus releasing aglycones that might be
absorbed in a lesser extent and, more probably, degraded
to simpler phenolic derivatives [38, 39]. Degradation of
flavonoid aglycones by colonic microbiota involves ring-
C cleavage and reactions affecting functional groups, such
as dehydroxylation, demethylation, or decarboxylation [39].
Various hydroxylated aromatic compounds derived from the
A-ring (e.g., phloroglucinol, 3,4-dihydroxybenzaldehyde, or
3,4-dihydroxytoluene) and phenolic acids derived from the
B-ring have been reported as relevant products of the colonic
transformation of flavonoids [40]. It has become evident
that the beneficial effects attributed to dietary polyphenols
appear to be due more to phenolic metabolites formed in the
gastrointestinal tract, mainly derived from the action of gut
bacteria, rather than to the original forms found in food [41].
In subsequent sections, main findings related to the
modulation of gut microbiota by polyphenols are presented
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as obtained from different methodological approaches and
microbial analysis techniques.
4. Studies Using Batch Culture Fermentations
Although in vivo human or animal intervention trials are
physiologically most relevant to study both polyphenol
metabolism and microbial modulation, in vitro tools have
been designed to simulate intestinal conditions. In combi-
nation with in vivo trials, in vitro experiments may help to
elucidate the extent bioconversion processes mediated by the
host itself [42, 43]. The complexity of in vitro gut models is
diverse, ranging from simple static models (batch culture fer-
mentation) to advanced continuous models (gastrointestinal
simulators).
Simple, static gut models, also known as batch-type
cultures, are generally closed systems using sealed bottles
or reactors containing suspensions of fecal material that are
maintained under anaerobic conditions. They are relatively
easy to operate and cost-effective, have a fair throughput,
and allow for parallel screening. This model approach is
primarily used to assess the stability of polyphenols in the
presence of human-derived gut microbiota and to evaluate
which environmental conditions favor or limit polyphenol
bioconversion. However, these static gut models are only
adequate for simulating short-term conditions in the gut;
for assessment of long-term adaptations of the gut microbial
community, more complex dynamic models are needed
[12].
Table 1 reports different studies of modulation of gut
microbiota by dietary polyphenols using batch-type cultures.
Details about fermentation conditions (fecal concentration,
polyphenol origin and dose, and incubation time) andmicro-
bial techniques used, and main effects on bacteria groups
(growth enhancement, growth inhibition, or no effect) have
been included. As general characteristics, fecal fermentations
employed feces concentration ≤10% (w/v) and lasted 48 h
maximum. Both pure phenolic compounds and phenolic-
rich extracts were added to the fecal medium at a final
concentration <10% (w/v), and changes in specific bacterial
groups weremainly assessed by FISH analysis. A first relevant
experiment using batch culture fermentation was carried
out by Tzounis et al. [44] who found that the flavan-3-ol
monomers [(−)-epicatechin and (+)-catechin] promoted the
growth of Clostridium coccoides-Eubacterium rectale group,
which is known to produce large amounts of butyrate, a short-
chain fatty acid (SCFA) with anti-inflammatory, and anti-
neoplasic properties; (+)-catechin also increased the growth
of Lactobacillus-Enterococcus spp., Bifidobacterium spp., and
Escherichia coli but decreased the growth of Clostridium
histolyticum. Also using standard compounds, Hidalgo et al.
[45] found that anthocyanins (i.e., malvidin-3-glucoside and
amixture of anthocyanins) significantly enhanced the growth
of Lactobacillus-Enterococcus spp. and Bifidobacterium spp.
In addition, malvidin-3-glucoside showed a tendency to
promote the growth of the C. coccoides-E. rectale group.
Similar results have been observed in batch culture
fermentations with phenolic-rich extracts from different
sources.Molan et al. [46] found that the addition of blueberry
extracts to a mixture of fecal bacterial populations signifi-
cantly increased the number of lactobacilli and bifidobacteria
(Table 1). In the same line, Bialonska et al. [47] reported
enhancement of the growth of total bacteria, Bifidobacterium
spp., and Lactobacillus-Enterococcus spp. in response to a
commercial extract of pomegranate, without influencing the
C. coccoides-E. rectale and C. histolyticum groups (Table 1).
Mandalari et al. [48] suggested a potential prebiotic effect
for natural and blanched almond skins as these foodstuffs, in
fermentations with fecal microbiota, significantly increased
the populations of bifidobacteria and C. coccoides-E. rectale
group and decreased the number of C. hystolyticum group.
These authors related the possible prebiotic effect by almond
skins not only to a high amount of dietary fibre, but also to
some phenolic compounds such as ferulic acid, flavan-3-ols,
and flavonols present in the almond skins [48]. Fogliano et al.
[49] carried out an in vitro fermentation with a water-
insoluble cocoa fraction in a three-stage continuous culture
colonicmodel system. It was observed that this cocoa fraction
presented prebiotic activity producing a significant increase
in lactobacilli and bifidobacteria, as well as an increase in
butyrate production. They concluded that the coexistence
of fermentable polysaccharides and free flavanol monomers
in cocoa, such as catechins, might be very effective in the
modification of gut microbiota. Similar conclusions were
drawn by Pozuelo et al. [50], who found a significant increase
of the growth of Lactobacillus reuteri and Lactobacillus
acidophilus in the presence of a grape antioxidant dietary fiber
naturally obtained from red grapes. Our research group car-
ried out several batch culture fermentations of two flavan-3-
ol fractions with different degree of polymerisation and wine
polyphenols, with fecal microbiota from different healthy
volunteers [51, 52]. Both flavan-3-ol fractions promoted the
growth ofLactobacillus/Enterococcus spp. and inhibited theC.
histolyticum group during fermentation, although the effects
were only statistically significant with the less polymerized
fraction.Wine polyphenols only showed a slight inhibition in
theC. histolyticum group, probably due to their lower content
in flavan-3-ols.
Additionally, this type of fermentations has also been
used to assess the contribution of certain probiotic strains
to the colonic metabolism of polyphenols. In this sense,
Barroso et al. [53] carried out fermentations of a red wine
extract inoculated with human microbiota obtained from
the colonic compartments of a dynamic simulator, in the
presence and absence of the probiotic strain L. plantarum
IFPL935. Microbial analysis by qPCR indicated that red
wine polyphenols induced greater variations among in vitro
batches harboring different colon-region (ascending colon,
descending colon, and effluent) microbiota than those found
when L. plantarum IFPL935 was added. Batches inoculated
with microbiota from the ascending colon were shown to
harbor the major proportion of saccharolytic bacteria (Bac-
teroides, Bifidobacterium, and Prevotella) whereas Clostrid-
ium groups were found in major numbers in the batches
inoculated with microbiota simulating the distal regions [53]
(Table 1).
BioMed Research International 5
Ta
bl
e
1:
St
ud
ie
su
sin
g
ba
tc
h
cu
ltu
re
fe
rm
en
ta
tio
n.
Re
fe
re
nc
e
Fe
ca
l
co
nc
en
tr
at
io
n
Ph
en
ol
ic
co
m
po
un
d/
fo
od
D
os
e
Ti
m
eo
f
in
cu
ba
tio
n
M
ic
ro
bi
al
te
ch
ni
qu
e
G
ro
w
th
en
ha
nc
em
en
t
G
ro
w
th
in
hi
bi
tio
n
N
o
eff
ec
t
Tz
ou
ni
se
ta
l.
(2
00
8)
[4
4]
10
%
,w
/v
(+
)-
ca
te
ch
in
15
0m
g/
L,
10
00
m
g/
L
<
48
h
FI
SH
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
Bi
fid
ob
ac
te
riu
m
sp
p.
C.
co
cc
oi
de
s-E
.r
ec
ta
le
gr
ou
p
E.
co
li
C.
hi
sto
ly
tic
um
gr
ou
p
M
ol
an
et
al
.(
20
09
)
[4
6]
0.
1%
,v
/v
Bl
ue
be
rr
y
ex
tr
ac
ts
5,
10
an
d
25
%
48
h
FI
SH
La
ct
ob
ac
ill
i
Bi
fid
ob
ac
te
ria
Bi
al
on
sk
ae
ta
l.
(2
01
0)
[4
7]
10
%
,w
/v
Po
m
eg
ra
na
te
ex
tr
ac
ta
nd
pu
ni
ca
la
gi
n
10
%
48
h
FI
SH
To
ta
lb
ac
te
ria
Bi
fid
ob
ac
te
riu
m
sp
p.
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
C.
co
cc
oi
de
s-E
.r
ec
ta
le
gr
ou
p
C.
hi
sto
ly
tic
um
gr
ou
p
M
an
da
la
ri
et
al
.
(2
01
0)
[4
8]
10
%
,w
/v
A
lm
on
d
sk
in
s
1%
,w
/v
pr
ed
ig
es
te
d
al
m
on
d
sk
in
s
<
24
h
FI
SH
Bi
fid
ob
ac
te
ria
C.
co
cc
oi
de
s-E
.r
ec
ta
le
gr
ou
p
C.
hi
sto
ly
tic
um
gr
ou
p
Fo
gl
ia
no
et
al
.
(2
01
1)
[4
9]
5%
,w
/v
W
at
er
-in
so
lu
bl
e
co
co
af
ra
ct
io
n
1%
,w
/v
36
h
FI
SH
Bi
fid
ob
ac
te
ria
La
ct
ob
ac
ill
i
Cu
ev
ae
ta
l.
(2
01
3)
[5
1]
10
%
,w
/v
G
ra
pe
se
ed
ex
tr
ac
t
fr
ac
tio
ns
30
0–
45
0m
g/
L
<
48
h
FI
SH
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
C.
hi
sto
ly
tic
um
gr
ou
p
H
id
al
go
et
al
.
(2
01
2)
[4
5]
10
%
,w
/v
M
al
vi
di
n-
3-
O
-
gl
uc
os
id
e
A
nt
ho
cy
an
id
in
s
m
ix
tu
re
20
m
g/
L
an
d
20
0m
g/
L
48
50
m
g/
L
an
d
48
50
0m
g/
L
<
24
h
FI
SH
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
Bi
fid
ob
ac
te
riu
m
sp
p.
C.
co
cc
oi
de
s-
E.
re
ct
al
e
gr
ou
p
Sa´
nc
he
z-
Pa
ta´
n
et
al
.(
20
12
)[
52
]
1%
w
/v
Re
d
w
in
ee
xt
ra
ct
60
0m
g/
L
48
h
FI
SH
C.
hi
sto
ly
tic
um
gr
ou
p
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
Ba
rr
os
o
et
al
.
(2
01
3)
[5
3]
Re
d
w
in
ee
xt
ra
ct
50
0m
g/
L
48
h
qP
CR
La
ct
ob
ac
ill
us
sp
p.
Bi
fid
ob
ac
te
riu
m
sp
p.
Ba
ct
er
oi
de
ss
pp
.
Ru
m
in
oc
oc
cu
ss
pp
.
6 BioMed Research International
Table 2: Studies using the gastrointestinal simulators (i.e., SHIME).
Reference Simulator Phenoliccompound/food Dose Time
Microbial
technique
Population
increase Population decrease
De Boever
et al. (2000)
[57]
SHIME Soy germ powder 2.5 g/day 2 weeks Plate count
Enterobacteriaceae
Coliforms
Lactobacillus spp.
Staphylococcus spp.
Clostridium spp.
Kemperman
et al. (2013)
[31]
Twin-
SHIME Black tea extract
3 × daily
dosing
(1000mg
polyphenols
as total daily
dose)
2 weeks
Plate count
qPCR
PCR-DGGE
pyrosequencing
Klebsiella spp.
Enterococci
Akkermansia spp.
Bifidobacteria
Blautia coccoides
Anaeroglobus spp.
Victivallis spp.
Kemperman
et al. (2013)
[31]
Twin-
SHIME
Red wine-grape
extract
3 × daily
dosing
(1000mg
polyphenols
as total daily
dose)
2 weeks
Plate count
qPCR
PCR-DGGE
pyrosequencing
Klebsiella spp.
Alistipes spp.
Cloacibacillus spp.
Victivallis spp.
Akkermansia spp.
Bifidobacteria
Blautia coccoides
group
Anaeroglobus spp.
Subdoligranulum spp.
Bacteroides
5. Studies Using Human
Gastrointestinal Simulators
In contrast to short-duration experiments with static gut
models, longer-term experiments are required when the
adaptation of the gut microbial community to dietary
polyphenols needs to be assessed. To this end, dynamic in
vitro gut models such as the “Reading” model [54], the
Simulator of the Human Intestinal Microbial Ecosystem
(SHIME), the TNO Intestinal Model 2 (TIM2) [55, 56], and
the recent gastrointestinal simulator set up in our Institute
(SIMGI) (unpublished work) have been developed where gut
microbiota are cultured over a longer time frame (days to
weeks) in one or multiple connected, pH controlled vessels
representing different parts of the gastrointestinal tract.
As an example of the versatility and potential of human
gastrointestinal simulators, Table 2 reports a series of studies
about modulation of gut microbiota by polyphenols using
the SHIME [57, 58].This validatedmodel comprises stomach
and small intestinal sections for predigestion of food as
well as vessels stimulating the ascending, transcending, and
descending parts of the human colon, allowing assessment of
changes in the different colonic areas that are very challenging
to access in a human intervention. However, it should be
underlined that this approach takes for granted that the
extracts reach intact the colonic region, and no nutrient
absorption is considered.The use of the SHIME to investigate
the effects of a soy germ powder on the fermentative capacity
of the simulated microbiota of the colon was the aim of a
study carried out by De Boever et al. [57].They observed that
the addition of the soy germ powder in a 2-week treatment
resulted into an overall increase of bacterial marker pop-
ulations (Enterobacteriaceae, coliforms, Lactobacillus spp.,
Staphylococcus spp., and Clostridium spp.), with a significant
increase of 2 log10 units in the Lactobacillus spp. population.
More recently, Kemperman et al. [31], using the twin-SHIME
model, studied the influence of a bolus dose and a 2-week
continuous administration of complex dietary polyphenols
from black tea or red wine grape extracts on the colonic
microbiota. The Twin-SHIME system, involving two models
that run in parallel, was inoculatedwith the same fecal sample
for direct comparison of the effect of the two polyphenol
types. A combination of analyses including cultivation, PCR-
denaturing gradient gel electrophoresis (DGGE), quantita-
tive PCR, and high throughput pyrosequencing of the 16S
ribosomal RNA gene was applied to characterize micro-
bial community changes. This study showed that complex
polyphenols in the context of a model system can modulate
select members of the human gut microbiota, revealing novel
targets potentially involved in polyphenolmetabolism and/or
resistant microbes to be further investigated for polyphenol
metabolism or resistance mechanisms [31].
6. Animal Models Studies
It is widely assumed that preliminary evidence should be
warranted in animal models before human intervention
trials. Animal models contribute to better understanding the
mechanisms and biological effects that could be likely to
happen in the human body. The metabolism of polyphenols
has been object of numerous animal studies (mostly in
rodents), especially for their impact on metabolic disorders
[58], but only a few of these studies have followed the
dynamics and composition of the intestinal microbiota in
association with polyphenol metabolites retrieved from the
host. Caution is required in extrapolating results to humans
because culture-independent comparisons have revealed that
most bacterial genera and species found in mice are not seen
in humans, although the distal gut microbiota of mice and
humans harbors the same bacterial phyla [59]. In this section,
studies performed in animals in order to assess the effects of
polyphenols on the modulation of intestinal microbiota are
BioMed Research International 7
Table 3: Animal model studies.
Reference Animal Phenoliccompound/food Dose
Treatment
duration
Microbial
technique Population increase Population decrease
Hara et al.
(1995) [60] Pigs Tea polyphenols 0.2% (free access) 2 weeks Plate count Lactobacilli
Total bacteria
Bacteroidaceae
C. perfringens
Ishihara et al.
(2001) [61] Calves Green tea extracts 1.5 g/day 4 weeks Plate count
Bifidobacterium spp.
Lactobacillus spp.
C. perfringens
Smith and
Mackie (2004)
[66]
Rats
Proantocyanidins
extracted from
Acacia
angustissima
0.7% (low tannin
diet) and 2.0%
(high tannin diet)
3.5 weeks
treatment +
3.5 weeks
washout
PCR-DGGE
Dot blot
hybridization
Bacteroides fragilis
group
Bacteroides-
Prevotella-
Porphyromonas group
Enterobacteriaceae
C. leptum group
Dolara et al.
(2005) [62] Rats
Red wine
polyphenols
powder
50mg/kg 16 weeks Plate count LactobacilliBifidobacteria
Propionibacteria
Bacteroides
Clostridia
Sembries et al.
(2006) [63] Rats Apple juice free access 4 weeks Plate count
Lactobacilli
Bifidobacteria
Sembries et al.
(2003) [64] Rats
Apple pomace
juice colloid
5% suppl. diet
(free access) 6 weeks
Plate count
FISH Bacteroidaceae
Larrosa et al.
(2009) [68] Rats Resveratrol 1mg/kg/day 25 days Plate count
Lactobacilli
Bifidobacteria
Molan et al.
(2010) [69] Rats
Blackcurrant
extracts (leaf or
berry)
3 times/week:
(i) 30mg/kg
(leaf)
(ii) 13.4mg/kg
(berry)
4 weeks FISH
Lactobacilli (berry
extract)
Bifidobacteria (leaf
and berry extracts)
Viveros et al.
(2011) [65]
Broiler
chicks
Grape pomace
concentrate
(GPC) Grape
seed extract
(GSE)
60 g/kg diet
(GPC)
7.2 g/kg diet
(GSE)
(free access)
21 days Plate countT-RFLP
E. coli
Enterococcus spp.
Lactobacillus spp.
Lacombe et al.
(2013) [70] Rats
Lowbush wild
blueberries
20 g feed/day
(eq. 24 ± 5.2mg
anthocyanin/day)
6 weeks Metagenomicsequencing
Thermonospora spp.
Corynebacteria spp.
Slackia spp.
Lactobacillus spp.
Enterococcus spp.
summarized (Table 3). Experiments were mainly performed
in rats, although other larger animals such as chicks, calves,
or pigs have also been used. Gut microbial communities were
evaluated by diverse methodologies including culture-based
methods (plate count), DGGE, FISH, T-RFLP, qPCR, and
metagenomic sequencing.
Animal studies performed in pigs [60] and in calves
[61] demonstrated that tea polyphenols administration con-
tributed to the improvement in the composition of the intesti-
nal microbiota. Thus, the administration of tea polyphenols
in pigs significantly increased the levels of lactobacilli whilst
it diminished the levels of total bacteria and Bacteroidaceae,
and a tendency to decrease in lecithinase positive clostridia
includingC. perfringenswas also observed [60]. However, the
reduction rate of Bifidobacterium spp. and Lactobacillus spp.
was slow,while that ofC. perfringensdecreased faster in calves
supplemented with the green tea extract [61].
Dolara et al. [62] showed that treatment with wine
polyphenols in carcinogen-treated F344 rats was associated
with a strong variation in the colonic microbiota, compared
to the control-fed rats. Although the total bacterial counts and
anaerobe/aerobe ratio of microorganisms in the feces from
polyphenol-treated rats were similar to that from control rats,
propionibacteria, Bacteroides, and Clostridia decreased while
lactobacilli and bifidobacteria increased. Based on additional
experiments, these authors concluded that reduction of
oxidative damage, modulation of colonic flora, and variation
in gene expression may be all connected in the action of wine
polyphenols on the intestinal function and carcinogenesis.
In other study, rats fedwith apple juice instead of drinking
water showed more lactobacilli and bifidobacteria in fresh
feces that differed from the controls by one-log10 colony
forming units [63]. The same research group studied the
effect of colloids isolated from apple pomace extraction juices
on the intestinal microbiota in Wistar rats. An increase
of Bacteroidaceae in almost one-log10 higher counts was
observed in feces of rats fed with apple juice colloid than
control rats [64]. Another animal experiment conducted to
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study the effect on intestinal microbiota, of the inclusion
of grape pomace extracts in the diet of broiler chicks [65],
found that, for the cecum, birds fed grape extracts had higher
populations of E. coli, Lactobacillus, and Enterococcus species
than birds in any other treatment group. These authors
concluded that grape polyphenol-rich products modified the
gut morphology and intestinal microbiota and increased the
biodiversity degree of intestinal bacteria in broiler chicks.
Inclusion of condensed tannins (proanthocyanidins)
extracted from Acacia angustissima on rat diet resulted in
a shift in the predominant bacteria towards tannin-resistant
Gram-negative Enterobacteriaceaeand Bacteroides species
and reduced the number of Gram-positive C. leptum group
[66]. Compatible results were obtained in an experiment
with rats fed a proanthocyanidin-rich cocoa preparation [67],
where the authors found a significant decrease in the propor-
tion of Bacteroides, Clostridium, and Staphylococcus genera
in the feces of cocoa-fed animals. Interestingly, reductions in
Clostridium species were found to correlate with weight loss
and decrease in body mass index.
Larrosa et al. [68] observed an increase in lactobacilli
and bifidobacteria when resveratrol (3,5,4󸀠-trihydroxy-trans-
stilbene), which naturally occurs in grapes and grape-derived
foodstuffs such as red wine, was administered to rats. After
induction of colitis by dextran sulphate sodium, proliferation
of both E. coli and enterobacteria was lower in rats treated
with resveratrol than in control rats. This could be the result
of an indirect effect of resveratrol-supplemented diet, which
increased bifidobacteria and lactobacilli counts preventing
the colonization and invasion of tissues by enterobacteria
including E. coli.
Prebiotic activity of wild blackcurrant extracts observed
in in vitro experiments was further confirmed in rats by
Molan et al. [69]. A significant increase in the population
size of lactobacilli and bifidobacteria was observed after daily
administration of those extracts to rats. Similarly, a grape
antioxidant dietary fibre preparation was found to increase
the population of Lactobacillus spp. when fed to rats, whereas
populations of Bifidobacterium spp. decreased and changes in
E. coli and Bacteroides vulgatus counts were not significant
[50].
Recently, Lacombe et al. [70] studied the composition and
functional potential of the colon microbiota from rats fed
a diet enriched in lowbush wild blueberries. Application of
novel metagenomic techniques (Illumina shotgun sequenc-
ing) revealed a significant reduction in the relative abundance
of the genera Lactobacillus and Enterococcus associated with
wild blueberries intake. In addition, hierarchical analysis
showed a significant increase in the relative abundance
of the phylum Actinobacteria, the order Actinomycetales,
and several novel genera under the family Bifidobacteri-
aceae and Coriobacteriaceae in the blueberries group. The
authors indicated that although the microbiome of rats
differs from humans, the applied model was a powerful
tool to study population dynamics and related metabolic
functions. Metagenomic studies can determine microbial
community profiles, gene presence/absence and abundance,
and functional repertoire; however, they can only infer an
observed phenotype since a gene presence does not imply its
expression or functionality [71].
7. Human Intervention Studies
Investigations involving the use of humans potentially pro-
vide the best models for studying the interactions of food
components (e.g., polyphenols) with microbiota, although in
vivo intervention trials hold inevitable practical and ethical
limitations [12]. The use of cross-over designs where volun-
teers serve as their own control permits multilevel analysis
schemes that increase power but requires a relevant number
of volunteers to allow for statistically significant multivariate
models [72]. Up to now, only a few studies have examined
the in vivo impact of dietary polyphenols on the human
gut microbiota, and most of them were focused on single
polyphenol molecules and selected bacterial populations. A
summary of human intervention studies about effects of
polyphenols in the modulation of the intestinal microbiota
is collected in Table 4. In these studies, the polyphenol dose
used was much dependent on the type of food preparation
and its concentration, normally ranging from 0.1 to 4%; the
treatment time was also variable, from 10 days to 2 months,
and the applied microbial techniques were diverse (plate
count, DGGE, FISH, T-RFLP, and qPCR).
In a study with a reduced number of subjects (𝑛 =
8), Okubo et al. [73] reported a notably increase in the
percentages of Bifidobacterium spp. in total fecal counts
after an intervention with a product containing 70% of tea
polyphenols. A significant decrease of C. perfringens and
other Clostridium spp. was also observed during the intake
period. However, in a crossover feeding study (number of
volunteers not reported) that investigated the effects of black
tea drinking on hypercholesterolemic volunteers, Mai et al.
[74] found that although specific bacterial groups were not
affected, the total amount of bacteria significantly decreased,
highlighting large interindividual variations. More recently,
an intervention study (𝑛 = 10) by Jin et al. [75] confirmed
an overall tendency for the proportion of bifidobacteria to
increase because of green tea consumption, even though
there were interindividual differences in the Bifidobacterium
species.
Yamakoshi et al. [76] showed that administration of a
proanthocyanidin-rich extract from grape seeds to healthy
volunteers (𝑛 = 9) significantly increased the fecal number of
Bifidobacterium, whereas the number of putrefactive bacteria
such as enterobacteria tended to decrease. The interaction
between proanthocyanidins and intestinal bacteria was also
confirmed in a randomized, double-blind, crossover, and
controlled intervention study (𝑛 = 22) ingesting two cocoa
drinks exhibiting low and high polyphenol content [77].
Compared with the consumption of the low-flavan-3-ol
cocoa drink, the daily consumption of the high-flavan-3-
ol cocoa drink significantly increased the bifidobacteria and
lactobacilli populations but significantly decreased clostridia
counts.
Queipo-Ortun˜o et al. [78] performed a randomized,
crossover, and controlled trial (𝑛 = 10) consisting of the
intake of red wine, dealcoholized red wine, and gin over
BioMed Research International 9
Ta
bl
e
4:
H
um
an
in
te
rv
en
tio
n
stu
di
es
.
Re
fe
re
nc
e
Vo
lu
nt
ee
r
nu
m
be
r
Ph
en
ol
ic
co
m
po
un
d/
fo
od
D
os
e
Tr
ea
tm
en
t
du
ra
tio
n
M
ic
ro
bi
al
te
ch
ni
qu
e
Po
pu
la
tio
n
in
cr
ea
se
Po
pu
la
tio
n
de
cr
ea
se
N
o
eff
ec
t
O
ku
bo
et
al
.
(19
94
)[
73
]
8
G
re
en
te
a
(S
un
ph
en
on
)
0.
4g
/3
tim
es
pe
r
da
y
4
w
ee
ks
Pl
at
ec
ou
nt
C.
pe
rfr
in
ge
ns
Cl
os
tri
di
um
sp
p.
Ya
m
ak
os
hi
et
al
.(
20
01
)[
76
]
9
Pr
oa
nt
oc
ya
ni
di
n-
ric
h
ex
tr
ac
tf
ro
m
gr
ap
es
ee
ds
0.
5g
/d
ay
6
w
ee
ks
Pl
at
ec
ou
nt
Bi
fid
ob
ac
te
riu
m
sp
p.
En
te
ro
ba
ct
er
ia
ce
ae
M
ai
et
al
.
(2
00
4)
[7
4]
15
Bl
ac
k
te
a
70
0m
g
te
as
ol
id
s/
5
tim
es
pe
rd
ay
21
da
ys
FI
SH
D
G
G
E
To
ta
lb
ac
te
ria
N
o
ch
an
ge
s
Cl
av
el
et
al
.
(2
00
5)
[8
3]
39
Is
ofl
av
on
es
10
0m
g/
da
y
2
m
on
th
s
TT
G
E
FI
SH
C.
co
cc
oi
de
s-E
.r
ec
ta
le
gr
ou
p
Bi
fid
ob
ac
te
riu
m
sp
p.
La
ct
ob
ac
ill
us
-
En
te
ro
co
cc
us
sp
p.
Fa
ec
al
ib
ac
te
riu
m
pr
au
sn
itz
ii
su
bg
ro
up
C
os
ta
bi
le
et
al
.
(2
00
8)
[8
4]
31
W
ho
le
gr
ai
n
w
he
at
ce
re
al
s
48
g/
da
y
3
w
ee
ks
FI
SH
Bi
fid
ob
ac
te
ria
La
ct
ob
ac
ill
i
To
ta
lb
ac
te
ria
Ba
ct
er
oi
de
ss
pp
.
C.
hi
sto
ly
tic
um
/p
er
fri
ng
en
s
gr
ou
p
Ac
et
ob
ac
te
riu
m
sp
p.
Ja
qu
et
et
al
.
(2
00
9)
[8
7]
16
C
off
ee
3
cu
ps
/d
ay
3
w
ee
ks
FI
SH
D
G
G
E
Bi
fid
ob
ac
te
riu
m
sp
p.
Ca
rv
al
ho
-
W
el
ls
et
al
.
(2
01
0)
[8
5]
32
W
ho
le
gr
ai
n
m
ai
ze
ce
re
al
s
48
g/
da
y
3
w
ee
ks
FI
SH
Bi
fid
ob
ac
te
ria
To
ta
lb
ac
te
ria
Ba
ct
er
oi
de
ss
pp
.
C.
hi
sto
ly
tic
um
/p
er
fri
ng
en
s
gr
ou
p
Ac
et
ob
ac
te
riu
m
sp
p.
G
ill
et
al
.
(2
01
0)
[8
0]
10
Ra
sp
be
rr
y
pu
re
e
20
g/
da
y
4
da
ys
PC
R-
D
G
G
E
N
o
ch
an
ge
si
n
th
ep
ro
fil
eo
f
co
lo
ni
cb
ac
te
ria
Sh
in
oh
ar
ae
t
al
.(
20
10
)[
79
]
8
Ap
pl
es
2
ap
pl
es
/d
ay
2
w
ee
ks
Pl
at
ec
ou
nt
La
ct
ob
ac
ill
us
sp
p.
St
re
pt
oc
oc
cu
ss
pp
.
En
te
ro
co
cc
us
sp
p.
En
te
ro
ba
ct
er
ia
ce
ae
le
ci
th
in
as
e-
po
sit
iv
e
clo
st
rid
ia
in
clu
di
ng
C.
pe
rfr
in
ge
ns
,
Ps
eu
do
m
on
as
sp
p.
10 BioMed Research International
Ta
bl
e
4:
C
on
tin
ue
d.
Re
fe
re
nc
e
Vo
lu
nt
ee
r
nu
m
be
r
Ph
en
ol
ic
co
m
po
un
d/
fo
od
D
os
e
Tr
ea
tm
en
t
du
ra
tio
n
M
ic
ro
bi
al
te
ch
ni
qu
e
Po
pu
la
tio
n
in
cr
ea
se
Po
pu
la
tio
n
de
cr
ea
se
N
o
eff
ec
t
Tz
ou
ni
se
ta
l.
(2
01
1)
[7
7]
22
C
oc
oa
fla
va
no
l
49
4m
g/
da
y
29
m
g/
da
y
4
w
ee
ks
FI
SH
Bi
fid
ob
ac
te
riu
m
sp
p.
La
ct
ob
ac
ill
us
sp
p.
C.
hi
sto
ly
tic
um
/p
er
fri
ng
en
s
gr
ou
p
Ve
nd
ra
m
ee
t
al
.(
20
11
)[
81
]
15
W
ild
bl
ue
be
rr
y
dr
in
k
25
g
w
ild
bl
ue
be
rr
ie
s/d
ay
6
w
ee
ks
qP
CR
Bi
fid
ob
ac
te
riu
m
sp
p.
L.
ac
id
op
hi
lu
s
Ba
ct
er
oi
de
ss
pp
.
Pr
ev
ot
ell
a
sp
p.
En
te
ro
co
cc
us
sp
p.
C.
co
cc
oi
de
s
Q
ue
ip
o-
O
rt
un˜
o
et
al
.
(2
01
2)
[7
8]
10
Re
d
w
in
e
27
2m
L/
da
y
20
da
ys
qP
CR
En
te
ro
co
cc
us
sp
p.
Pr
ev
ot
ell
a
sp
p.
Ba
ct
er
oi
de
s
Bi
fid
ob
ac
te
riu
m
sp
p.
Ba
ct
er
oi
de
su
ni
fo
rm
is
Eg
ge
rt
he
lla
len
ta
Bl
au
tia
co
cc
oi
de
s-E
.
re
ct
al
eg
ro
up
Cl
os
tri
di
um
sp
p.
C.
hi
sto
ly
tic
um
gr
ou
p
Ac
tin
ob
ac
te
ria
Jin
et
al
.(
20
12
)
[7
5]
10
G
re
en
te
a
10
00
m
L/
da
y
10
da
ys
T-
RF
LP
qP
CR
Bi
fid
ob
ac
te
riu
m
sp
p.
G
ug
lie
lm
et
ti
et
al
.(
20
13
)[
82
]
15
W
ild
bl
ue
be
rr
ie
s
dr
in
k
25
g
w
ild
bl
ue
be
rr
ie
s/d
ay
6
w
ee
ks
qP
CR
B.
lo
ng
um
su
bs
p.
in
fa
nt
is
Cu
er
vo
et
al
.
(2
01
4)
[8
6]
38
D
ai
ry
pr
od
uc
ts
Fr
ui
ts
Ve
ge
ta
bl
es
C
er
ea
ls
Fo
od
in
ta
ke
w
as
re
co
rd
ed
us
in
g
an
an
nu
al
fo
od
fre
qu
en
cy
qu
es
tio
nn
ai
re
qP
CR
La
ct
ob
ac
ill
us
B.
co
cc
oi
de
s
C.
lep
tu
m
BioMed Research International 11
three consecutive periods. After the red wine period, the
bacterial concentrations of proteobacteria, fusobacteria, Fir-
micutes, and Bacteroidetes markedly increased compared
with the washout period; significant increases in the num-
ber of Bifidobacterium spp. and Prevotella spp. were also
observed. However, Lactobacillus spp., Clostridium spp., and
C. histolyticum group concentrations remained unchanged
throughout the study.
In a small-scale observational study (𝑛 = 8), Shinohara
et al. [79] found that the number of bifidobacteria in feces
significantly increased during apple intake and the numbers
of Lactobacillus spp., Streptococcus spp., and Enterococcus
spp. tended to increase. On the contrary, enterobacteria
and lecithinase-positive clostridia, including C. perfringens
and Pseudomonas species, tended to decrease. However,
that study did not use culture-independent microbiology
techniques and suffered from the lack of a control group.
Also in relation to fruits, another small human intervention
study (𝑛 = 10) with raspberry puree [80] did not observe
statistically significant alterations in the profile of colonic
bacteria, probably due to high interindividual variation in
fecal bacteria, although the profiles of microbial metabolites
of raspberry polyphenols varied greatly between individuals,
indicating that the type of gut microbiota affects catabolite
profiles released by bacteria in the colon.This lack of effect on
the intestinal microbiota after the intake of raspberry puree
might also be due to the short duration of the treatment, as
well as the techniques employed to quantify the intestinal
microbiota.
Vendrame et al. [81] studied the potential prebiotic
activity of a drink elaborated fromwild blueberries especially
rich in anthocyanins, in a small intervention trial (𝑛 = 15). A
significant increase in Bifidobacterium spp. and L. acidophilus
group was detected, while no significant differences were
observed for Bacteroides spp., Prevotella spp., Enterococcus
spp., and C. coccoides. In a further paper of the same group
[82], seven different intragenus bifidobacteria taxonomic
clusters that were among the most common and abundant
bifidobacteria species inhabiting the human gutwere targeted
in the same samples. It was found thatB. adolescentis,B. breve,
B. catenulatum/pseudocatenulatum, and B. longum subsp.
longumwere always present in the group of subjects enrolled,
whereas B. bifidum and B. longum subsp. infantis were not.
In spite of the large interindividual variability, a significant
increase of B. longum subsp. infantis cell concentration was
observed in the feces of volunteers after the wild blueberry
drink treatment, which was attributed to the presence of
prebiotic (bifidogenic) molecules from blueberries, possibly
fibers and glycosylated anthocyanins.
In a study with postmenopausal women (𝑛 = 39),
Clavel et al. [83] found that isoflavone supplementation
stimulated dominant microorganisms of the C. coccoides-E.
rectale cluster, Lactobacillus-Enterococcus group, Faecalibac-
terium prausnitzii subgroup, and Bifidobacterium genus. It
was also suggested that the concentration of C. coccoides-E.
rectale cluster was related to women capacity to excrete equol,
an intestinal metabolite from daidzein. In two intervention
studies with whole grain breakfast cereals from wheat (𝑛 =
31) and maize (𝑛 = 32) [84, 85], the ingestion of both
products resulted in significant increases in fecal bifidobac-
teria and/or lactobacilli without changing the relative abun-
dance of other dominant members of the gut microbiota.
Little or no changes were observed in the numbers of total
bacteria, Bacteroides spp., C. histolyticum/perfringens group,
and Acetobacterium spp. present in the feces. However, as
whole grains are good sources of dietary fiber, it is difficult to
ascribe the observed effects only to the phenolic compounds
present in these foods. In this respect, Cuervo et al. [86] have
recently studied the correlations between the intake of fiber
and polyphenols from diet and fecal microbiota composition
in a cohort of apparently healthy subjects. Results showed
that the intake of soluble pectins and flavanones fromoranges
presented a negative correlation with the levels of B. coccoides
and C. leptum. By contrast, the intake of white bread,
providing hemicellulose and resistant starch, was directly
correlated with Lactobacillus.
Finally, another human trial (𝑛 = 16) carried out by
Jaquet et al. [87] assessed the impact of a moderate con-
sumption of instant coffee on the general composition of
the human intestinal bacterial population. Coffee bever-
ages contain significant amounts of soluble fibre (mainly
galactomannans and arabinogalactan-proteins) and phenolic
compounds (chlorogenic acids), which arewell utilised by the
human fecal microbiota. It was observed that although fecal
profiles of the dominant microbiota were not significantly
affected after the consumption of the coffee, the population
of Bifidobacterium spp. increased, being the largest increase
observed for those volunteers showing the lowest initial
bifidobacteria levels.
8. Conclusions
This review has tried to summarize the current knowledge
in relation to the phenolic metabolism by gut microbiota and
themodulation of the gutmicrobiota by phenolic compounds
and polyphenol-rich dietary sources.There are evidences that
the beneficial effects attribute to dietary polyphenols depend
on their biotransformation by the gut microbiota. Therefore,
it is important to investigate the bacterial species impli-
cated in the metabolism of dietary polyphenols, and further
research is still needed in relation to the resultant microbial
metabolites to ascertain their mechanisms of action. On
the other hand, a great number of in vitro and in vivo (in
animals andhumans) studies showing the influence of dietary
polyphenols on gut-inhabiting bacteria have been published
in recent years. Although in vitro assays facilitate experimen-
tation, caution must be taken in extrapolating results to in
vivo situation, as many factors are acting upon this process.
In general, in both in vitro and in vivo studies, polyphenols or
polyphenol-rich sources have shown to influence the relative
abundance of different bacterial groups within the gut micro-
biota, reducing numbers of potential pathogens, including C.
perfringens and C. histolyticum, and certain Gram-negative
Bacteroides spp. and enhancing mainly beneficial Clostridia,
bifidobacteria and lactobacilli. A better understanding of the
interaction between dietary polyphenols and gut microbiota
through the emerging advances in high-throughput meta-
genomic, transcriptomic, and proteomic approaches, would
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be essential in order to identify genes and micro-organisms
involved in polyphenol (in)activation and conversion and
thus, to elucidate the implications of diet on the modulation
of microbiota for delivering health benefits.
Functional foods are considered to enhance the protective
effects against diseases derived from some food components.
In the last decades, dairy fermented foods have probably
been one of the most-developed functional products and
have deserved intensive research. In this expansion, dairy
fermented foods have been supplemented with fruits, cereals,
and other stuffs of plant origin, all of which represent a high
percentage of the current market of the dairy industry. These
products have a healthy appeal, which attracts consumers.
Thus, fruit juices/concentrates, and prepared fruits (in the
form of pieces, pulp, and even flour) have been successfully
incorporated in dairy fermented foods as sources of prebiotic
fibers and phytochemicals. Among these phytochemicals
present in plant-derived foods, polyphenols have gained
much interest due to their diverse potential beneficial effects
in human health. The supplementation of dairy fermented
products with rich-polyphenolic stuffs (phenolic extracts,
phenolic-enriched fractions, etc.) seems to be an effective
technological option to improve the benefits of these products
in the balance of the intestinal microbiota, due not only to the
action of the probiotics but also to the potential modulation
effects exerted by polyphenols, as it has been described in this
review. Further research in this area will aim to accomplish
the benefits of both probiotic strains and polyphenols in
relation to gut health.
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